Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid in Hip Osteoarthritis
NCT04303026Phase 3Unknown
- Sponsor
- Vestre Viken Hospital Trust
- Start
- Mar 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hip osteoarthritis comparing Zoledronic Acid Group with Placebo Group (2 arms). Primary endpoint: Visual Analogue Scale Pain at 12 months. Status: unknown.
02
Drugs
zoledronic acid
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NCT04303026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04303026.